Qiu Bensheng, Yang Xiaoming
Image-Guided Bio-Molecular Interventions Section, Department of Radiology, University of Washington School of Medicine, 1959 NE Pacific Street, HSC AA-036, Seattle, WA 98195, USA.
Nat Clin Pract Cardiovasc Med. 2008 Jul;5(7):396-404. doi: 10.1038/ncpcardio1217. Epub 2008 May 13.
A characteristic feature of atherosclerotic cardiovascular disease is the diffuse involvement of arteries across the entire human body and the presence of multiple, simultaneous lesions. The diffuse nature of this disease creates a unique challenge for early diagnosis and effective treatment. We believe that recent progress in the field of molecular MRI has opened new avenues towards solving the problem. A new technology has been developed that uses molecular MRI to monitor the migration and homing of hematopoietic stem-progenitor cells to injured arteries and atherosclerosis. In this Review, we introduce several novel technical developments in the field of molecular MRI of atherosclerosis, including advanced techniques for magnetic labeling of stem-progenitor cells and molecular MRI of hematopoietic bone marrow cells migrating to injured arteries and homing to atherosclerotic plaques. In addition, we examine molecular MRI of vascular gene therapy mediated by stem-progenitor cells. These new techniques provide the basis for the further development of in vivo MRI techniques to monitor stem-cell-mediated vascular gene therapy for multiple and diffuse atherosclerotic cardiovascular lesions.
动脉粥样硬化性心血管疾病的一个特征是动脉在整个人体的弥漫性累及以及多个同时存在的病变。这种疾病的弥漫性性质给早期诊断和有效治疗带来了独特的挑战。我们认为,分子磁共振成像(MRI)领域的最新进展为解决这一问题开辟了新途径。已经开发出一种新技术,利用分子MRI监测造血干祖细胞向受损动脉和动脉粥样硬化部位的迁移和归巢。在本综述中,我们介绍动脉粥样硬化分子MRI领域的几项新技术进展,包括用于干祖细胞磁性标记的先进技术以及造血骨髓细胞向受损动脉迁移并归巢至动脉粥样硬化斑块的分子MRI。此外,我们还研究了由干祖细胞介导的血管基因治疗的分子MRI。这些新技术为进一步开发体内MRI技术以监测针对多发性和弥漫性动脉粥样硬化性心血管病变的干细胞介导的血管基因治疗奠定了基础。